Alzheimer’s drug failure leaves Biogen in a precarious place - STAT

Alzheimer’s drug failure leaves Biogen in a precarious place - STAT

STAT Plus: Alzheimer’s drug failure leaves Biogen in a precarious place

By ADAM FEUERSTEIN AND MATTHEW HERPER

RUBY WALLAU FOR STAT

Biogen must find a new way to grow — or perhaps find another company that would like to buy it.

READ MORE